In vivo, In vitro and In silico Aphrodisiac Activity of the Hydroalcoholic Fruit Extract of Fragaria ananassa in Male Wistar Rats for the Treatment of Erectile Dysfunction Induced by Metronidazole
Abstract
Erectile dysfunction (ED) is one of the most common sexual disorders in men which occurs due to various biological, environment and rarely genetic factors. The study is conducted due to various side effects of the currently available erectile dysfunction drugs such as PDE 5 inhibitor. The objective of the study is to evaluate the aphrodisiac activity of Fragaria ananassa fruit extract in drug-induced erectile dysfunction in rats. The fruit of Fragaria ananassa was extracted by the hydroalcoholic extraction method and evaluated for its preliminary phytochemical investigation and further molecular docking studies were carried out. The hydroalcoholic extract of the fruit at different doses (500mg/kg and 1000mg/kg) is used for in vivo studies carried out in rats and various physical mating parameters, serum testosterones, FSH, LH, AST, ALT, TC, and antioxidant SOD, CAT and LPO were estimated along with the histopathology studies and compared with standard sildenafil (4.5mg/kg). The phytochemicals screening confirms the presence of the flavonoids, glycosides, phenols, in Fragaria ananassa fruit extract (FAFE). In metronidazole induced model, FAFE shows a significant effect against dysfunction by improving the serum hormonal levels and restoration of the natural antioxidant system (SOD, CAT & LPO) and histology of the testis, which serves as evidence for the aphrodisiac activity of FAFE. From the present study, it can be concluded that the hydroalcoholic extract of Fragaria…
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.